Thyrocare FY26 Results: Profit Up, Recommends Rs 7 Dividend

Board approved audited standalone and consolidated financial results for Q4 and FY ended March 31, 2026, with unmodified audit opinion.
Recommended a final dividend of Rs. 7.00 per equity share for FY 2025-26, bringing total dividend to Rs. 9.33 per share post-bonus adjustment.
Approved appointment of M/s. Price Waterhouse as new Statutory Auditors and re-appointed Mr. Rahul Guha as MD & CEO for five years.
Approved investment of up to Rs. 5.50 crores in wholly-owned subsidiary Think Health Diagnostics and alteration of Memorandum of Association.